Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
    • GP-001 Documents and records control
    • GP-002 Quality planning
      • Deprecated
        • R-002-001 Quality objectives list_2023_001
        • R-002-002 Quality objectives_2023_001
        • R-002-002 Quality objectives_2023_002
        • R-002-002 Quality objectives_2023_003
        • R-002-002 Quality objectives_2023_004
        • R-002-002 Quality objectives_2023_005
        • R-002-002 Quality objectives_2023_006
        • R-002-003 Quality indicators_2022_001
        • R-002-003 Quality indicators_2023_001
        • R-002-004 Annual management review report_2023_001
        • R-002-005 Quality Calendar_2023_001
        • R-002-005 Quality Calendar_22_001
        • R-002-006 SWOT and CAME analysis_2023_001
        • R-002-007 Process validation card 2023_013
        • R-002-008 Quality and regulatory roadmap_2023_001
      • R-002-001 Quality objectives list_2024_001
      • R-002-001 Quality objectives list_2025
      • R-002-002 Quality objectives_2024_001
      • R-002-002 Quality objectives_2024_002
      • R-002-002 Quality objectives_2024_003
      • R-002-002 Quality objectives_2024_004
      • R-002-002 Quality objectives_2024_005
      • R-002-002 Quality objectives_2025_001
      • R-002-002 Quality objectives_2025_002
      • R-002-002 Quality objectives_2025_003
      • R-002-002 Quality objectives_2025_004
      • R-002-002 Quality objectives_2025_005
      • R-002-003 Quality indicators_2024
      • R-002-004 Annual management review report
      • R-002-005 Quality Calendar_2025
      • R-002-006 SWOT and CAME analysis
      • R-002-007
      • R-002-008 Quality and regulatory roadmap
      • R-002-009 Regulatory requirements review report
    • GP-003 Audits
    • GP-004 Vigilance system
    • GP-005 HR and training
    • GP-007 Post-market surveillance
    • GP-009 Sales
    • GP-010 Suppliers
    • GP-012 Design, Redesign and Development
    • GP-018 Infrastructure and facilities
    • GP-019 Software validation
    • GP-023 Change control management
    • GP-050 Data Protection
    • GP-051 Security violations
    • GP-052 Data Privacy Impact Assessment (DPIA)
    • GP-200 Remote Data Acquisition in Clinical Investigations
  • TF_Legit.Health_Plus
  • Licenses and accreditations
  • External documentation
  • Records
  • GP-002 Quality planning
  • Deprecated
  • R-002-002 Quality objectives_2023_006

R-002-002 Quality objectives_2023_006

Objective details​

Objective number: 6​

Description​

To perform the MHRA registration to obtain the approval to sell our product at the UK market

Establishment date​

18th January 2022

Planning​

Responsible​

JD-004

Departments involved​

The main department developing the objective is the Quality and Regulatory one.

Planned actions for 2023 period​

  1. Find and sign a contract with a "UK Responsible Person".
  2. Perform the MHRA registration
  3. Archive the evidence of the approval
  4. Disseminate the achievement

Resources needed​

  • Financial resources to pay the UK Responsible Person (approximately 3000 €)
  • Personnel for the follow up of the activities.

Monitoring and follow up​

Period% CompletionFollow upShort-term actions
Q1100%Apotech is our "UK Responsible Person". They completed the registration and sent us the corresponding certificate. Our UK customers were informed.Not required
Q2
Q3
Q4

Status​

  • [] In progress
  • Completed
  • [] Extended
  • [] Discarded

Record signature meaning

  • Author: JD-004 María Diez
  • Review and approval: JD-001 Andy Aguilar
Previous
R-002-002 Quality objectives_2023_005
Next
R-002-003 Quality indicators_2022_001
  • Objective details
    • Objective number: 6
    • Description
    • Establishment date
  • Planning
    • Responsible
    • Departments involved
    • Planned actions for 2023 period
    • Resources needed
  • Monitoring and follow up
  • Status
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)